SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-22-042568
Filing Date
2022-04-05
Accepted
2022-04-05 08:28:10
Documents
6
Period of Report
2022-05-19

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm223487-1_def14a.htm DEF 14A 651697
2 GRAPHIC lg_bioxceltherapeutics-4c.jpg GRAPHIC 70338
3 GRAPHIC sg_javierrodriguez-bw.jpg GRAPHIC 21623
4 GRAPHIC sg_petermueller-bw.jpg GRAPHIC 10983
5 GRAPHIC tm223487d1-px_page01bw.jpg GRAPHIC 762218
6 GRAPHIC tm223487d1-px_page02bw.jpg GRAPHIC 764426
  Complete submission text file 0001104659-22-042568.txt   2892747
Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Filer) CIK: 0001720893 (see all company filings)

IRS No.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38410 | Film No.: 22805295
SIC: 2834 Pharmaceutical Preparations